Health TrialsbyHealthPanel

Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor

ConditionPityriasis Versicolor
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-50
SponsorKhyber Teaching Hospital

About this trial

This study compares the efficacy of two drugs, namely flucanazole and itraconazole for the treatment of a common fungal infection of skin.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All cases of Pityriasis versicolor

Disqualifiers

Patients with history of chronic renal or liver disease, malignancy , or undergoing any kind of chemotherapy or radiotherapy or having cardiac conduction abnormalities.

Patients who received any anti-fungal therapy in the last one month.

Pregnant or lactating women.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Fluconazole

    Drug

    Oral fluconazole prescribed to group A

  • Itraconazole

    Drug

    Oral itraconazole prescribed to Group B

Treatment groups

106 Participants
are divided into 2 treatment groups
Group A: Group A, Fluconazole groupExperimental treatment 1 intervention
Group B: Group B, Itraconazole groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Efficacy of Treatment

Efficacy of treatment is defined by absence of scaling by naked eye examination ,absence of yellow or golden scale reflection on woods lamp examination and absence of fungal hyphae on microscopic examination.

Time frame
Upto 8 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Khyber Teaching Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now